logo
episode-header-image
Jan 2024
41 m

Episode 087: Prostate Cancer Series: Pt....

Rouleaux University Medical Center
About this episode
tail spinning
Up next
Apr 22
Episode 153: Myeloma Capstone, Pt 2 - MRD-Guided Therapy, Maintenance, and Relapsed/Refractory Sequencing
Therapy, Maintenance, and Relapsed/Refractory SequencingThis week, we kick off the first of our myeloma capstone roundtable discussions with two experts who treat myeloma every single day. We welcome back Dr. Manni Mohyuddin from the Huntsman Cancer Institute at the University of ... Show More
28m 26s
Apr 15
Episode 152: Myeloma Capstone, Pt 1 - Smoldering Myeloma & Frontline Treatment in the Elderly
This week, we kick off the first of our myeloma capstone roundtable discussions with two experts who treat myeloma every single day. We welcome back Dr. Manni Mohyuddin from the Huntsman Cancer Institute at the University of Utah, and introduce a new friend of the show, Dr. Adeel ... Show More
25m 46s
Apr 8
Episode 151: Myeloma Series, Pt. 11 - Role of bispecific T-cell engagers for relapsed/refractory multiple myeloma (2026)
In this week’s episode, we continue our journey through the relapsed/refractory myeloma space, with a focus on the role of bispecific T-cell engagers. Another incredibly important conversation that is so important in the current treatment landscape and one that you don’t want to ... Show More
27m 5s
Recommended Episodes
Apr 2025
#343 – The evolving role of radiation: advancements in cancer treatment, emerging low-dose treatments for arthritis, tendonitis, and injuries, and addressing misconceptions | Sanjay Mehta, M.D.
tail spinning
2h 12m
Jan 2024
Episode 165: A Radiation Oncology Perspective on the PROSPECT Trial
Salma Jabbour, MD, Professor and Vice Chair of Radiation Oncology at Rutgers Cancer Institute, provides an invaluable perspective rooted in her extensive experience and passion for radiation oncology. Dr. Jabbour delves into the transformative changes witnessed in radiation oncol ... Show More
47m 13s
Oct 2023
Radiation Oncology and the Abscopal Effect in TNBC
What does the cutting edge of radiation oncology look like for treating triple-negative breast cancer? Tune in to hear experts Drs Kevin Kalinsky and Reshma Jagsi discuss. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarti ... Show More
18m 34s
Sep 2025
Colorectal Cancer
Send us Fan MailNinja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob discuss Colorectal Cancer. This comprehensive discussion focuses on the clinical presentation, pathogenesis, and management of one of the most common malignancies encountered in clinical practice. ... Show More
37m 25s
Jan 2024
Episode 288: APCCC #3: Controversies around Radiotherapy
Thomas Zilli discusses controversies around radiotherapy in prostate cancer. 
36m 29s
Sep 2025
Prostate Cancer
Send us Fan MailNinja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob break down the essential clinical and pathophysiologic features of Prostate Cancer, one of the most common malignancies affecting men worldwide.We begin with the epidemiology and risk factors, hig ... Show More
34m 59s
Oct 2025
53: Can Thyroid Health Help Prevent Cancer? – The Root-Cause Approach to Healing with Dr. Leigh Erin Connealy
Can thyroid issues increase your cancer risk—or could they hold the key to preventing it altogether?In this episode of the Modern Thyroid and Wellness Podcast, host McCall McPherson welcomes renowned integrative physician Dr. Leigh Erin Connealy, author of The Cancer Revolution. ... Show More
53m 29s
Sep 2025
Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain
In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington U ... Show More
53m 8s
Jun 2022
Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate
<p>Patients with metastatic breast cancer whose tumors express low levels of HER2 are generally classified and treated as having HER2-negative disease.</p> <p>However, Dr. Shanu Modi of the Memorial Sloan Kettering Cancer Center and a group of international collaborators explored ... Show More
11m 24s
Dec 2024
141. Back to Basics - The role of endocrine therapy in Breast Cancer
<p>Before immunotherapy, targeted chemotherapy (ADCs) and precision oncology, there was endocrine therapy, the forefather (or mother) of effective treatment to reduce breast cancer recurrence as well as delay disease progression. This episode dives into a past of phenomenal impro ... Show More
24m 4s